These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29886291)

  • 21. Reversibility of White Matter Hyperintensity by Revascularization Surgery in Moyamoya Disease.
    Komatsu K; Mikami T; Noshiro S; Miyata K; Wanibuchi M; Mikuni N
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1495-502. PubMed ID: 27038979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring Cerebral Perfusion Changes after Revascularization in Patients with Moyamoya Disease by Using Arterial Spin-labeling MR Imaging.
    Lee S; Yun TJ; Yoo RE; Yoon BW; Kang KM; Choi SH; Kim JH; Kim JE; Sohn CH; Han MH
    Radiology; 2018 Aug; 288(2):565-572. PubMed ID: 29714677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged Mean Transit Time Detected by Dynamic Susceptibility Contrast Magnetic Resonance Imaging Predicts Cerebrovascular Reserve Impairment in Patients with Moyamoya Disease.
    Kawano T; Ohmori Y; Kaku Y; Muta D; Uekawa K; Nakagawa T; Amadatsu T; Kasamo D; Shiraishi S; Kitajima M; Kuratsu J
    Cerebrovasc Dis; 2016; 42(1-2):131-8. PubMed ID: 27088711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staging Hemodynamic Failure With Blood Oxygen-Level-Dependent Functional Magnetic Resonance Imaging Cerebrovascular Reactivity: A Comparison Versus Gold Standard (
    Fierstra J; van Niftrik C; Warnock G; Wegener S; Piccirelli M; Pangalu A; Esposito G; Valavanis A; Buck A; Luft A; Bozinov O; Regli L
    Stroke; 2018 Mar; 49(3):621-629. PubMed ID: 29371433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of moyamoya disease using multidetector row computed tomography.
    Sugino T; Mikami T; Ohtaki S; Hirano T; Iihoshi S; Houkin K; Mikuni N
    J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):644-9. PubMed ID: 22365710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bayesian Estimation of CBF Measured by DSC-MRI in Patients with Moyamoya Disease: Comparison with
    Hara S; Tanaka Y; Hayashi S; Inaji M; Maehara T; Hori M; Aoki S; Ishii K; Nariai T
    AJNR Am J Neuroradiol; 2019 Nov; 40(11):1894-1900. PubMed ID: 31601573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Moyamoya disease with 3.0-T magnetic resonance angiography and magnetic resonance imaging versus conventional angiography.
    Jin Q; Noguchi T; Irie H; Kawashima M; Nishihara M; Takase Y; Gong H; Uchino A; Matsushima T; Kudo S
    Neurol Med Chir (Tokyo); 2011; 51(3):195-200. PubMed ID: 21441735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging.
    Noguchi T; Kawashima M; Irie H; Ootsuka T; Nishihara M; Matsushima T; Kudo S
    Eur J Radiol; 2011 Dec; 80(3):e557-62. PubMed ID: 21315533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of 7.0- and 3.0-T MRI and MRA in ischemic-type moyamoya disease: preliminary experience.
    Deng X; Zhang Z; Zhang Y; Zhang D; Wang R; Ye X; Xu L; Wang B; Wang K; Zhao J
    J Neurosurg; 2016 Jun; 124(6):1716-25. PubMed ID: 26544772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Endothelial Shear Stress on the Bilateral Progression of Unilateral Moyamoya Disease.
    Lee WJ; Jeong SK; Han KS; Lee SH; Ryu YJ; Sohn CH; Jung KH
    Stroke; 2020 Mar; 51(3):775-783. PubMed ID: 31856692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive Assessment of Oxygen Extraction Fraction in Chronic Ischemia Using Quantitative Susceptibility Mapping at 7 Tesla.
    Uwano I; Kudo K; Sato R; Ogasawara K; Kameda H; Nomura JI; Mori F; Yamashita F; Ito K; Yoshioka K; Sasaki M
    Stroke; 2017 Aug; 48(8):2136-2141. PubMed ID: 28663515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic improvement of anterior cerebral artery territory perfusion induced by bifrontal encephalo(periosteal) synangiosis in pediatric patients with moyamoya disease: a study with brain perfusion SPECT.
    Song YS; Oh SW; Kim YK; Kim SK; Wang KC; Lee DS
    Ann Nucl Med; 2012 Jan; 26(1):47-57. PubMed ID: 22033781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Added Value of Vessel Wall Magnetic Resonance Imaging in the Differentiation of Moyamoya Vasculopathies in a Non-Asian Cohort.
    Mossa-Basha M; de Havenon A; Becker KJ; Hallam DK; Levitt MR; Cohen WA; Hippe DS; Alexander MD; Tirschwell DL; Hatsukami T; Amlie-Lefond C; Yuan C
    Stroke; 2016 Jul; 47(7):1782-8. PubMed ID: 27272486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The leptomeningeal ivy sign on fluid-attenuated inversion recovery images in moyamoya disease: positron emission tomography study.
    Kaku Y; Iihara K; Nakajima N; Kataoka H; Fukushima K; Iida H; Hashimoto N
    Cerebrovasc Dis; 2013; 36(1):19-25. PubMed ID: 23920347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moyamoya Vessel Pathology Imaged by Ultra-High-Field Magnetic Resonance Imaging at 7.0 T.
    Dengler NF; Madai VI; Wuerfel J; von Samson-Himmelstjerna FC; Dusek P; Niendorf T; Sobesky J; Vajkoczy P
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1544-51. PubMed ID: 27053027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of surgical revascularization on cerebral oxygen metabolism in patients with Moyamoya disease: an 15O-gas positron emission tomographic study.
    Kuroda S; Kashiwazaki D; Hirata K; Shiga T; Houkin K; Tamaki N
    Stroke; 2014 Sep; 45(9):2717-21. PubMed ID: 25116870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ivy sign, misery perfusion, and asymptomatic moyamoya disease: FLAIR imaging and (15)O-gas positron emission tomography.
    Vuignier S; Ito M; Kurisu K; Kazumata K; Nakayama N; Shichinohe H; Shiga T; Kiss JZ; Tamaki N; Houkin K
    Acta Neurochir (Wien); 2013 Nov; 155(11):2097-104. PubMed ID: 24036671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the cortical artery using computed tomography angiography for bypass surgery in moyamoya disease.
    Suzuki H; Mikami T; Komatsu K; Noshiro S; Miyata K; Hirano T; Wanibuchi M; Mikuni N
    Neurosurg Rev; 2017 Apr; 40(2):299-307. PubMed ID: 27476115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetazolamide-challenged perfusion magnetic resonance imaging for assessment of cerebrovascular reserve capacity in patients with symptomatic middle cerebral artery stenosis: comparison with technetium-99m-hexamethylpropyleneamine oxime single-photon emission computed tomography.
    Kim HJ; Kim TW; Ryu SY; Yang PS; Kwon MJ; Kim JC; Lee YS; Lee HJ; Yang JH; Kim JK; Chung YA; Oh EY; Lee SB
    Clin Imaging; 2011; 35(6):413-20. PubMed ID: 22040783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Childhood moyamoya disease: hemodynamic MRI.
    Tzika AA; Robertson RL; Barnes PD; Vajapeyam S; Burrows PE; Treves ST; Scott RM
    Pediatr Radiol; 1997 Sep; 27(9):727-35. PubMed ID: 9285733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.